Table 3 In-hospital clinical outcomes
|  | 30-day-survival group (n = 18) | 30-day-mortality group (n = 14) | p-value |
|---|---|---|---|
Cardiogenic shock | 14 (78%) | 14 (100%) | 0.11 |
Atrial fibrillation | 8 (44%) | 6 (43%) | > 0.99 |
High-grade heart block | 0Â (0%) | 3 (21%) | 0.07 |
Acute kidney injury | 8 (44%) | 12 (86%) | 0.028 |
Dialysis | 6 (33%) | 9 (64%) | 0.15 |
Major bleeding events | 4 (22%) | 7 (50%) | 0.14 |
Stroke | 1 (6%) | 0 (0%) | > 0.99 |
Sepsis | 8 (44%) | 4 (29%) | 0.47 |
Pneumonia | 3 (18%) | 1 (7%) | 0.61 |